These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8382384)

  • 1. T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection.
    Gjertsen HA; Lundin KE; Hansen T; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):70-1. PubMed ID: 8382384
    [No Abstract]   [Full Text] [Related]  

  • 2. T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection.
    Gjertsen HA; Lundin KE; Hansen T; Thorsby E
    Transpl Immunol; 1993; 1(2):126-31. PubMed ID: 8081770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene-derived peptides: a new class of tumor rejection antigens?
    Gedde-Dahl T; Olsen BH; Thorsby E; Gaudernack G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1385-6. PubMed ID: 8442151
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.
    Narimatsu H; Murata M; Terakura S; Sugimoto K; Naoe T
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):397-402. PubMed ID: 18342781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
    Berle EJ; Thorsby E
    Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity.
    Miceli MC; Barry TS; Finn OJ
    Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040
    [No Abstract]   [Full Text] [Related]  

  • 7. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA mismatch and graft rejection].
    Matsuyoshi H; Senju S; Monji M; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():621-31. PubMed ID: 15861720
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
    Strauss G; Osen W; Knape I; Jacobsen EM; Müller SM; Debatin KM
    Cell Death Differ; 2007 Mar; 14(3):480-8. PubMed ID: 16902496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The propagation of HLA-specific T cells from failed corneal grafts.
    Pollack MS; Washington J; Matoba A
    Transplant Proc; 1987 Feb; 19(1 Pt 1):408-9. PubMed ID: 3274795
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural model of HLA-DR1 restricted T cell antigen recognition.
    Rothbard JB; Lechler RI; Howland K; Bal V; Eckels DD; Sekaly R; Long EO; Taylor WR; Lamb JR
    Cell; 1988 Feb; 52(4):515-23. PubMed ID: 2963699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II induction of human corneal fibroblasts by cell-free supernatants from HSV stimulated lymphocytes.
    Young E; Pepose JS
    Curr Eye Res; 1987 Jan; 6(1):141-4. PubMed ID: 3030637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report.
    Heo WB; Kim CD; Won DI
    Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
    Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
    Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of allorecognition by use of synthetic peptides.
    Colovai AI; Renna-Molajoni E; Cocciolo PL; Tugulea S; Liu Z; Harris PE; Suciu-Foca N; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3029-31. PubMed ID: 8962175
    [No Abstract]   [Full Text] [Related]  

  • 17. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of liver allograft rejection: the indirect recognition pathway.
    Molajoni ER; Cinti P; Orlandini A; Molajoni J; Tugulea S; Ho E; Liu Z; Suciu-Foca N; Cortesini R
    Hum Immunol; 1997 Mar; 53(1):57-63. PubMed ID: 9127148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organ transplantation and immune response].
    Ochiai T; Arii S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():632-7. PubMed ID: 15861721
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated.
    Pfeffer PF; Foerster A; Frøysaker T; Simonsen S; Thorsby E
    Transplant Proc; 1988 Jun; 20(3):367-8. PubMed ID: 3289163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.